[go: up one dir, main page]

ATE204576T1 - Methotrexat-derivate - Google Patents

Methotrexat-derivate

Info

Publication number
ATE204576T1
ATE204576T1 AT93902536T AT93902536T ATE204576T1 AT E204576 T1 ATE204576 T1 AT E204576T1 AT 93902536 T AT93902536 T AT 93902536T AT 93902536 T AT93902536 T AT 93902536T AT E204576 T1 ATE204576 T1 AT E204576T1
Authority
AT
Austria
Prior art keywords
methotrexate derivatives
antirheumatic
chem
iii
image
Prior art date
Application number
AT93902536T
Other languages
English (en)
Inventor
Hiroharu Matsuoka
Hiroshi Suzuki
Nobuaki Kato
Keiichiro Tsuji
Toshio Kuroki
Noriaki Maruyama
Kazuya Nakagomi
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE204576T1 publication Critical patent/ATE204576T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT93902536T 1992-01-27 1993-01-27 Methotrexat-derivate ATE204576T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP5305192 1992-01-27
JP7510692 1992-02-13
JP10832092 1992-03-16
JP11512692 1992-03-24
PCT/JP1993/000096 WO1993015077A1 (en) 1992-01-27 1993-01-27 Methotrexate derivative

Publications (1)

Publication Number Publication Date
ATE204576T1 true ATE204576T1 (de) 2001-09-15

Family

ID=27462860

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902536T ATE204576T1 (de) 1992-01-27 1993-01-27 Methotrexat-derivate

Country Status (10)

Country Link
US (2) US6559149B1 (de)
EP (1) EP0632038B1 (de)
KR (1) KR100248324B1 (de)
AT (1) ATE204576T1 (de)
AU (1) AU3367693A (de)
CA (1) CA2128205C (de)
DE (1) DE69330639T2 (de)
ES (1) ES2161713T3 (de)
TW (1) TW223637B (de)
WO (1) WO1993015077A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100248324B1 (ko) * 1992-01-27 2000-04-01 나가야마 오사무 메토트렉세이트 유도체
CN1037771C (zh) * 1992-12-25 1998-03-18 中外制药株式会社 甲氨喋呤衍生物
EP0818199A4 (de) * 1995-03-27 2002-08-14 Chugai Pharmaceutical Co Ltd Ein methotrexatderivat enthaltendes medikament
US7276506B2 (en) * 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
EP1283199A4 (de) * 2000-05-16 2003-12-17 Takeda Chemical Industries Ltd Antagonisten des melanin-konzentrierenden hormons
US20070032477A1 (en) * 2003-10-17 2007-02-08 Waer Mark J A Pteridine derivatives useful for making pharmaceutical compositions
US20060039985A1 (en) * 2004-04-27 2006-02-23 Bennett David B Methotrexate compositions
US7601834B2 (en) * 2005-02-22 2009-10-13 Savvipharm Inc Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives
SG170037A1 (en) 2005-11-28 2011-04-29 Verrow Pharmaceuticals Inc Compositions useful for reducing nephrotoxicity and methods of use thereof
WO2007098089A2 (en) * 2006-02-17 2007-08-30 Novacea, Inc. Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs
US10144736B2 (en) * 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
US9259426B2 (en) 2006-07-20 2016-02-16 Gilead Sciences, Inc. 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
AU2008237934B2 (en) 2007-04-11 2014-03-27 Merck & Cie 18F-labelled folates
MX2011004006A (es) 2008-11-19 2011-05-19 Pola Chem Ind Inc Agentes antiarrugas.
ES2801380T3 (es) 2015-03-04 2021-01-11 Gilead Sciences Inc Compuestos de 4,6-diamino-pirido [3,2-d] pirimidina y su utilización como moduladores de receptor de tipo toll
ES2826748T3 (es) 2016-09-02 2021-05-19 Gilead Sciences Inc Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll
AU2017318601B2 (en) 2016-09-02 2020-09-03 Gilead Sciences, Inc. Toll like receptor modulator compounds
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
EP3990455A1 (de) 2019-06-28 2022-05-04 Gilead Sciences, Inc. Verfahren zur herstellung von toll-like-rezeptor-modulatorverbindungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI812775L (fi) * 1980-09-12 1982-03-13 Farmos Oy Foerfarande foer framstaellning av n-/4-/(2,4-diamino-6-pteridinyl)-metyl/metylamino/benzoyl/glutaminsyra och derivat daerav
US4490529A (en) * 1983-09-06 1984-12-25 Dana-Farber Cancer Institute, Inc. Cysteic acid and homocysteic acid analogues of methotrexate and aminopterin
CN1032858C (zh) * 1990-08-14 1996-09-25 中外制药株式会社 新颖的甲氨蝶呤衍生物的制造方法
JP3124592B2 (ja) * 1990-08-14 2001-01-15 中外製薬株式会社 新規メトトレキセート誘導体
JP3207285B2 (ja) * 1992-01-27 2001-09-10 中外製薬株式会社 新規メトトレキセート誘導体
KR100248324B1 (ko) * 1992-01-27 2000-04-01 나가야마 오사무 메토트렉세이트 유도체
JP3274532B2 (ja) * 1992-03-24 2002-04-15 中外製薬株式会社 抗リウマチ剤

Also Published As

Publication number Publication date
ES2161713T3 (es) 2001-12-16
DE69330639T2 (de) 2002-07-04
US6559149B1 (en) 2003-05-06
CA2128205A1 (en) 1993-08-05
EP0632038A4 (de) 1995-02-22
EP0632038A1 (de) 1995-01-04
KR100248324B1 (ko) 2000-04-01
US20030171376A1 (en) 2003-09-11
TW223637B (de) 1994-05-11
CA2128205C (en) 2004-03-30
DE69330639D1 (de) 2001-09-27
WO1993015077A1 (en) 1993-08-05
EP0632038B1 (de) 2001-08-22
AU3367693A (en) 1993-09-01

Similar Documents

Publication Publication Date Title
ATE204576T1 (de) Methotrexat-derivate
DE69533277D1 (de) Dc-89 derivat
IL96882A0 (en) Uracil derivatives and pesticides containing the same as active ingredient
AU628138B2 (en) Triazine derivative and herbicide containing the same as active ingredient
FI914928A0 (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
MX9300222A (es) Nuevos derivados de arilcicloalquilo, su preparacion y su utilizacion.
ZA916268B (en) Tricyclic compound or salts thereof,method for producing the same and antimicrobial agent containing the same
AU7415387A (en) Imidazolesulfonamide derivatives and herbicides
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
DK0676399T3 (da) Methotrexaderivater
DE69533573D1 (de) Anxiolytischer wirkstoff
DE69314573D1 (de) 2-Thiazolylpyrroleakrylate mit fungizider Wirkung